From magic spot ppGpp to MESH1: Stringent response from bacteria to metazoa
PLOS Pathogens · 02.02.2023 · 19 (2) · e1011105
DOI: 10.1371/journal.ppat.1011105 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 02.02.2023. Verfasst von Jen-Tsan Chi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Guanosine Tetraphosphate, Bacteria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, United States of America.
- Duke Center for Genomic and Computation Biology, Duke University School of Medicine, Durham, North Carolina, United States of America.
- Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, United States of America.
ORCID-Profile: Jen-Tsan Chi
Förderung
- NIGMS NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- National Institute of Health
- U.S. Department of Defense
Zitieren
APA
Chi, J. T., & Zhou, P. (2023). From magic spot ppGpp to MESH1: Stringent response from bacteria to metazoa. PLOS Pathogens, 19(2), e1011105. https://doi.org/10.1371/journal.ppat.1011105
Vancouver
Chi JT, Zhou P. From magic spot ppGpp to MESH1: Stringent response from bacteria to metazoa. PLOS Pathogens. 2023;19(2):e1011105. doi:10.1371/journal.ppat.1011105
BibTeX
@article{Chi2023,
author = {Chi, Jen-Tsan and Zhou, Pei},
title = {From magic spot ppGpp to MESH1: Stringent response from bacteria to metazoa},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {2},
pages = {e1011105},
doi = {10.1371/journal.ppat.1011105}
}
EUVIMED